Artículos de revistas
Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy
Registro en:
Gene. Elsevier Science Bv, v. 515, n. 2, n. 391, n. 395, 2013.
0378-1119
WOS:000315307100022
10.1016/j.gene.2012.12.059
Autor
Oliveira-Paula, GH
Lacchini, R
Coeli-Lacchini, FB
Moreno, H
Tanus-Santos, JE
Institución
Resumen
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Hypertension is a multifactorial disorder associated with increased inducible nitric oxide synthase (iNOS) expression and activity. While genetic polymorphisms affect iNOS expression, it is not known whether iNOS gene polymorphisms affect the susceptibility to hypertension and the responses to antihypertensive therapy. This study aimed at assessing whether iNOS polymorphisms ((CCTTT)(n), g.-1026C>A, and g.2087G>A) and haplotypes are associated with hypertension and with responsiveness to drug therapy. We studied 115 well controlled hypertensive patients (HTN), 82 hypertensive patients resistant to optimized antihypertensive therapy (RHTN), and 113 normotensive healthy subjects (NT). Genotypings were carried out using real-time polymerase chain reaction (PCR) and PCR amplification followed by capillary electrophoresis. The software PHASE 2.1 was used to estimate the haplotype frequencies in each group. Variant genotypes (GA + AA) for the g.2087G>A polymorphism were more commonly found in hypertensive patients (HTN + RHTN) than in normotensives (P=0.016; OR=2.05). We found no associations between genotypes and responsiveness to therapy (P>0.05). The S-C-A haplotype was more commonly found in hypertensive patients (HTN + RHTN) than in normotensives (P=0.014; OR=6.07). Interestingly, this haplotype was more commonly found in the HTN group than in the RHTN group (P=0.012; OR=0.14). Our findings indicate that the g.2087G>A polymorphism in the iNOS gene affects the susceptibility to hypertension. Moreover, while the S-C-A haplotype is associated with hypertension, it is also associated with responsiveness to antihypertensive therapy. (C) 2012 Elsevier B.V. All rights reserved. 515 2 391 395 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Improved identification of secondary hypertension: use of a systematic protocol
Kotliar, Carol Virginia; Obregón, Sebastián; Koretzky, Martin; Botto, Fernando; Di Leva, Ana; Boscaro, Marcelo; Ali, Ayan; Ferdinand, Keith C. (AME Publishing Company, 2018-08)Background: The accurate identification and diagnosis of secondary hypertension is critical, especially while atherosclerotic cardiovascular heart disease continues to be the leading cause of death in the industrialized ... -
The effects of experimental gestational hypertension on maternal blood pressure and fluid intake and pre-weanling hypothalamic neuronal activity
Arguelles J.; Perillan C.; Beltz T.G.; Xue B.; Badaue-Passos D.; Jr.; Vega J.A.; Johnson A.K. (Academic Press, 2017) -
Síndrome de Eisenmenger na gravidez
Borges, Vera Therezinha Medeiros; Magalhães, Claudia Garcia; Martins, Anice Maria V. C.; Matsubara, Beatriz Bojikian